Clinical Trials · NCT03085095
A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Myovant Sciences GmbH
- Enrollment
- 1,134
- Start date
- Apr 2017
- Locations
- 162 sites, 22 countries
- Primary endpoint
- Sustained Castration Rate